Skip to main content

Table 2 Treatment outcomes for participants finishing follow-up

From: Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017

  n (%)
Benguela Zaire Lunda Sul
DPb ASAQa ALa ASAQa ALa DPb
n = 85 n = 91 n = 94 n = 90 n = 91 n = 89
Treatment failure 5 (6) 1 (1) 7 (7) 16 (18) 9 (10) 0
 Early treatment failure 0 0 0 0 0 0
 Late treatment failure 5 (6) 1 (1) 7 (7) 16 (18) 9 (10) 0
 Recrudescence 0 0 4 (4) 5 (6) 3 (3) 0
  Day 21 0 0 1 (1) 5 (6) 3 (3) 0
  Day 28 0 0 3 (3) 0 0 0
  Day 35 0 0
  Day 42 0 0
 Reinfection 5 (6) 1 (1) 3 (3) 11 (12) 6 (7) 0
  Day 21 0 0 0 7 (8) 2 (2) 0
  Day 28 0 1 (1) 3 (3) 4 (4) 4 (4) 0
  Day 35 2 (2) 0
  Day 42 3 (4) 0
Adequate clinical and parasitological response 80 (94) 90 (99) 87 (93) 74 (82) 82 (90) 89 (100)
  1. AL artemether–lumefantrine, ASAQ artesunate–amodiaquine, DP dihydroartemisinin–piperaquine
  2. a28-day follow-up
  3. b42-day follow-up